Clinical Trial Update: Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating tirzepatide as monotherapy in patients with Wolfram Syndrome is ongoing, with the status not yet determined.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wolfram Syndrome

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Ospedale San Raffaele | Conditions: Wolfram Syndrome | Phase 2 | Status: UNKNOWN